Global pulmonary drugs market players are working in developing effective, quick and efficient medicines to meet the unmet demands of the patient population across the globe. This report encompasses a competitive landscape of the Pulmonary Drugs market. The report includes the detailed analysis (company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, and strategies, and future plans) of key market players such as Sanofi SA, Meda Pharmaceuticals, Circassia Pharmaceuticals Plc., AstraZeneca Plc., GlaxoSmithKline Plc., Mallinckrodt Pharmaceuticals Plc., Cheisi Farmaceuticals S.p.A, Zambon Company S.p.A, Alaxia SAS, and Merck Sharp & Dohme Limited.
The pulmonary drugs are used for treating the conditions affecting lungs. The pulmonary drugs are used from treating minor illnesses such as the common cold to cure long-term disorders such asthma. These agents are available in different forms such as oral tablets, oral liquids, and injections or inhalations. Inhalations deliver the medicine directly to the lungs, which can act directly on the lung tissues, minimizing systemic side effects.
According to latest market report on Pulmonary Drugs Market, the market can be segmented by Drug Class, Application, Distribution Channel, and Region - Global Trends, and forecast till 2025. Themajor factors driving growth of the pulmonary drugs market include increasing incidence of chronic respiratory diseases, tobacco smoking, and government and non-government initiatives.
The report presents the detailed segmentation of Global Pulmonary Drugs Market by drug class (Inhaled Corticosteroids, Long Acting Beta-2 Agonists, Antihistamines, Vasodilators, Short Acting Beta-2 Agonists and others), applications (Asthma & COPD, Allergic Rhinitis, Pulmonary Arterial, Hypertension, Cystic Fibrosis and others) and distribution channel (Hospital Pharmacies, Retail Pharmacies and E-Commerce).
Based on geography, the market has been segmented which includes geographical analysis based on drug class, application, distribution channel and country of North America, Latin America, Europe, Asia-Pacific and many more.